Relationship between FEV1 reduction and respiratory symptoms in the general population

European Respiratory Journal

Volumn 21, Issue 4, 2003, Pages 658-663

  Jakeways, N ^a   McKeever, T ^a   Lewis, S A ^a   Weiss, S T ^b   Britton, J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CHANNING LABORATORY   (United States)

Author keywords

Lung function; Respiratory symptons

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY AIRFLOW; RISK ASSESSMENT; SELF REPORT; SPIROMETER; SPIROMETRY; SYMPTOMATOLOGY; WHEEZING; ADOLESCENT; ADULT; AGED; FEMALE; MALE; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; VITAL CAPACITY;

ADOLESCENT; ADULT; AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VITAL CAPACITY;

EID: 0037384276     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00069603     Document Type: Article

References (28)

1. Hurd S. The impact of COPD on lung health worldwide - Epidemiology and incidence. Chest 2000; 117: 1-4.
2. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117: 5-9.
3. Lacasse Y, Brooks D, Goldstein RS. Trends in the epidemiology of COPD in Canada, 1980 to 1995. Chest 1999; 116: 306-313.
4. Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001; 17: 982-994.
5. Beasley R. The burden of asthma with specific reference to the United States. J Allergy Clin Immunol 2002; 109: S482-S489.
6. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 2000; 106: 493-499.
7. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996; 9: 636-642.
8. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S78-S119.
9. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
10. British Thoracic Society. Guidelines for the management of COPD. Thorax 1997; 52: Suppl. 5, S1-S28.
11. Ministry of Social Affairs and Health. Chronic bronchitis and chronic obstructive Pulmonary disease. National Guidelines for Prevention and Treatment 1998-2007. Helsinki, Ministry of Social Affairs and Health, 1998.
12. Fletcher C, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema. Oxford, Oxford University Press, 1976.
13. Kerstjens HM, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997; 52: 820-827.
14. Tweedale PM, Merchant S, Leslie M, Alexander F, McHardy GJR. Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits. Thorax 1984; 39: 928-932.
15. Tweedale PM, Alexander F, McHardy GJR. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 1987; 42: 487-490.
16. Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet 1994; 344: 357-362.
17. Quanjer PH. Standardised lung function testing. Bull Eur Physiopathol Respir 1983; 19: Suppl. 5, 5-92.
18. Saetta M, Turato G, Facchini FM, et al. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1633-1639.
19. Saetta M, Finkelstein R, Cosio MG. Morphological and cellular basis for airflow limitation in smokers. Eur Respir J 1994; 7: 1505-1515.
20. Lamb D, Mclean A, Gillooly M, Warren PM, Gould GA, MacNee W. Relation between distal airspace size, bronchiolar attachments, and lung function. Thorax 1993; 48: 1012-1017.
21. Nagai A, Yamawaki I, Takizawa T, Thurlbeck WM. Alveolar attachments in emphysema of human lungs. Am Rev Respir Dis 1991; 144: 888-891.
22. Mitchell RS, Stanford RE, Johnson JM, Silvers GW, Dart G, George MS. The morphologic features of the bronchi, bronchioles and alveoli in chronic airway obstruction: a clinicopathologic study. Am Rev Respir Dis 1976; 114: 137-145.
23. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45: 579-585.
24. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. A reexamination of risk factors for ventilatory impairment. Am Rev Respir Dis 1988; 138: 829-836.
25. Boezen HM, Rijcken B, Schouten JP, Postma DS. Breathlessness in elderly individuals is related to low lung function and reversibility of airway obstruction. Eur Respir J 1998; 12: 805-810.
26. Laszlo G, Nicholson EM, Denison J, Goddard PR. Adverse effect of previous bronchial asthma on disability in chronic airflow obstruction. Lancet 2000; 356: 737-738.
27. Tager IB, Segal MR, Speizer FE, Weiss ST. The natural history of forced expiratory volumes. Am Rev Respir Dis 1988; 138: 837-849.
28. Krzyzanowski M, Camilli AE, Lebowitz MD. Relationships between pulmonary function and changes in chronic respiratory symptoms. Comparison of Tucson and Cracow longitudinal studies. Chest 1990; 98: 62-70.